Tandem Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Tandem Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$772K	Buy	1,540 +5	+0.3%	+$2.4K	0.6%	37
2026 Q1	$754K	Sell	1,535 -25	-2%	-$13.6K	0.64%	39
2025 Q4	$904K	Sell	1,560 -262	-14%	-$148K	0.76%	35
2025 Q3	$884K	Buy	1,822 +1	+0.1%	+$465	0.73%	37
2025 Q2	$738K	Buy	1,821 +273	+18%	+$114K	0.64%	39
2025 Q1	$770K	Buy	1,548 +6	+0.4%	+$3.25K	0.76%	33
2024 Q4	$802K	Buy	+1,542	New	+$848K	0.77%	30

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Tandem Investment Partners's TMO Position: Q2 2026 in Review

Tandem Investment Partners increased its Thermo Fisher Scientific (TMO) stake by 0.33% in Q2 2026, buying an estimated $2.4K and bringing the position to 1,540 shares worth $772K. The position accounts for 0.6% of the portfolio, ranked #37.

Tandem Investment Partners first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $904K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Tandem Investment Partners held 1,540 shares of Thermo Fisher Scientific worth $772K as of Q2 2026.
Tandem Investment Partners bought 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
Thermo Fisher Scientific made up 0.6% of Tandem Investment Partners's portfolio in Q2 2026, its #37 holding.
Tandem Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
Tandem Investment Partners's Thermo Fisher Scientific position peaked at $904K in Q4 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Tandem Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.